PARP1 and non-small cell lung carcinoma: In non-small cell lung carcinoma cells, PARP-1 knockdown resulted in a reversal of EMT with an increase in epithelial markers such as β-catenin, and a prominent decrease in mesenchymal markers such as vimentin [93].